CAMBRIDGE, Massachusetts, Sept. 5 -- The Massachusetts Biotechnology Council issued the following statement on Sept. 4, 2026, by CEO Kendalle Burlin O'Connell:

* * *

CEO Innovation Policy Update 09.04.26

The House came back this week long enough to avert a government shutdown, while the Trump Administration followed through on last week's expected expansion of its drug pricing agenda to mid-sized biopharma. We also saw new movement on biotech bios . . .

Click here for more information about our products